Emgrast 300mcg Injection is a vital medication used to stimulate the production of white blood cells, specifically neutrophils, in the body. Its active ingredient is Filgrastim, a recombinant human granulocyte colony-stimulating factor (G-CSF). Filgrastim works by signaling the bone marrow to increase the production and release of neutrophils into the bloodstream. This is crucial for patients undergoing chemotherapy, which often suppresses the immune system and leads to a dangerous drop in neutrophil counts (neutropenia). By boosting neutrophil levels, Emgrast helps to reduce the risk of infections in these vulnerable individuals.
Indications for Emgrast 300mcg Injection include the prevention and treatment of neutropenia in patients receiving myelosuppressive chemotherapy for various cancers, as well as in patients undergoing bone marrow transplantation. It is also used to mobilize peripheral blood progenitor cells for autologous transplantation. The dosage and duration of treatment are determined by the patient’s medical condition, response to therapy, and the specific treatment regimen. It is typically administered subcutaneously or intravenously. Common side effects may include bone pain, fever, headache, and fatigue. It is essential to store Emgrast 300mcg Injection at a controlled room temperature, protected from light, and not to freeze it. Always follow your healthcare provider’s instructions for administration and storage.
